MENU
SGMO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sangamo Therapeutics (SGMO) Ownership - Who owns Sangamo Therapeutics?
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
501 Canal Boulevard
Phone
+1 510 970-6000
Employees
405
Web
https://www.sangamo.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
158.56M
P/E Ratio
N/A
Total Cash
41.92M
Projected Growth
N/A
Total Debt
30.57M
Revenue
57.8M
Risk (Beta)
1.67
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
0.29 USD as % of share price
Fundamentals
SGMO
Capitalization
159M
P/E Ratio
N/A
Risk (Beta)
1.67
Dividend Yield
N/A
Total Cash
41.9M
Total Cash/Share
0.19
Total Debt
30.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.29%
Revenue
57.8M
ROE
N/A
Book Value
22.8M
P/B Ratio
6.96
Cash Flow
N/A
Earnings
-0.49
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.13M
Current Ratio
1.13
Current Revenue Per Employee
41262.30
Dividends Per Share - Security
N/A
EBITDA
-89.09M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-73.38
Shares Held By Institutions
80.6M
Shares Outstanding - Current
225M
Total Liabilities
78.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-30.824
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of transcription factors in the regulation of genes
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
501 Canal Boulevard
Phone
+1 510 970-6000
Employees
405
Web
https://www.sangamo.com